United States — Food and Drug Administration & Glancy Prongay & Murray
5 shared events · Importance 3 · Last updated Aug 17, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration issued safety warnings concerning serious neurological complications in dogs related to Zoetis' Bedinvetmab, contributing to its weakening adoption.
Glancy Prongay & Murray: Glancy Prongay & Murray, a leading national shareholder rights law firm, announces a securities fraud class action lawsuit has been filed against Zoetis Inc.
May 18, 2026 · 316 articles
Regulatory
United States — Food and Drug Administration: The FDA rejected Replimune's BLA and published briefing documents raising concerns about the data package, triggering the stock drop and subsequent lawsuits. The FDA's actions are central to the event.
Glancy Prongay & Murray: Glancy Prongay & Murray filed a securities fraud lawsuit on behalf of Replimune investors.
Jul 29, 2026 · 65 articles
Regulatory
United States — Food and Drug Administration: Regulator whose briefing documents and advisory committee vote triggered the stock collapse and legal actions.
Glancy Prongay & Murray: Filed a class action lawsuit against Capricor.
Jul 27, 2026 · 293 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States — Food and Drug Administration and Glancy Prongay & Murray interact across events, view sentiment trends, and discover connected entities.
Open Dashboard